A Phase 3 Study to Evaluate the Efficacy and Safety of Pegozafermin in Subjects with Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Fibrosis

  • Braude, Michael (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date13/08/24 → 7/08/29